Gene therapy shows promise in children with devastating genetic disorder
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children s Hospitals.
The trial includes seven children aged 4 to 9 born with deficiency of AADC, an enzyme involved in the synthesis of neurotransmitters, particularly dopamine, that leaves them unable to speak, feed themselves or hold up their head. Six of the children were treated at UCSF and one at Ohio State Wexner Medical Center.
Children in the study experienced improved motor function, better mood, and longer sleep, and were able to interact more fully with their parents and siblings. Oculogyric crisis, a hallmark of the disorder involving involuntary upward fixed gaze that may last for hours and may be accompanied by seizure-like episodes, ceased in all but one patient. Results appear July 12, 20
Gene Therapy Restores Dopamine Levels in Kids With Rare Disorder
technologynetworks.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technologynetworks.com Daily Mail and Mail on Sunday newspapers.
Innovative gene therapy reprograms cells to reverse neurological deficiencies
osu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from osu.edu Daily Mail and Mail on Sunday newspapers.
Gene Therapy Offers Long-Awaited Hope for Children with Rare, Incurable Disorder
ucsf.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ucsf.edu Daily Mail and Mail on Sunday newspapers.
Novel method of gene therapy promises to transform the treatment of rare genetic disorder
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.